Parisa Zamiri
Geen lopende functies
Vermogen: 119 841 $ op 31-03-2024
Profiel
Parisa Zamiri worked as the Director of Pre-Clinical Sciences at Arsenal Medical, Inc. from 2007 to 2011.
She then worked as the VP and Global Head of Clinical Development at Novartis AG from 2012 to 2020.
In 2020, she became the Chief Medical Officer at Graybug Vision, Inc. Dr. Zamiri holds a doctorate degree from University College London and a graduate degree from King's College London.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CALCIMEDICA, INC.
0.27% | 23-03-2023 | 28 808 ( 0.27% ) | 119 841 $ | 31-03-2024 |
Eerdere bekende functies van Parisa Zamiri
| Bedrijven | Functie | Einde |
|---|---|---|
| CALCIMEDICA, INC. | Chief Tech/Sci/R&D Officer | 28-02-2023 |
| NOVARTIS AG | Corporate Officer/Principal | 01-06-2020 |
Arsenal Medical, Inc.
 Arsenal Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Arsenal Medical Inc. develops therapeutic products based on BioActive Composites platform. Its biomaterials-based systems provide targeted local and systemic therapies to treat chronic diseases and conditions. The firm product offers tailored dosing of drugs, mechanical and biochemical compatibility with tissues and complete bioabsorption. The company was founded by George M. Whitesides, Carmichael S. Roberts Jr. and Robert S. Langer Jr. in 2005 and is headquartered in Watertown, MA. | Corporate Officer/Principal | 01-11-2011 |
Opleiding van Parisa Zamiri
| University College London | Doctorate Degree |
| King's College London | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NOVARTIS AG | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Arsenal Medical, Inc.
Arsenal Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Arsenal Medical Inc. develops therapeutic products based on BioActive Composites platform. Its biomaterials-based systems provide targeted local and systemic therapies to treat chronic diseases and conditions. The firm product offers tailored dosing of drugs, mechanical and biochemical compatibility with tissues and complete bioabsorption. The company was founded by George M. Whitesides, Carmichael S. Roberts Jr. and Robert S. Langer Jr. in 2005 and is headquartered in Watertown, MA. | Commercial Services |
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Graybug Vision, Inc. develops ophthalmic drugs. It focus on developing drug delivery therapies for the treatment of eye diseases such as age-related macular degeneration and glaucoma. The company was founded by Justin S. Hanes, Peter John McDonnell, Christy Wyskiel and Peter A. Campochiaro in May 2011 and is headquartered in Redwood City, CA. | Health Technology |
